agilon health, inc. ( AGL ) Q3 2025 Earnings Call November 4, 2025 4:30 PM EST Company Participants Evan Smith - Senior Vice President of Investor Relations Ronald Williams - Executive Chairman Jeffrey Schwaneke - Executive VP & CFO Conference Call Participants Hua Ha - Robert W.
The headline numbers for Agilon (AGL) give insight into how the company performed in the quarter ended September 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Agilon Health (AGL) came out with a quarterly loss of $0.27 per share versus the Zacks Consensus Estimate of a loss of $0.18. This compares to a loss of $0.29 per share a year ago.
AGL, PLAY and CCRN have been added to the Zacks Rank #5 (Strong Sell) List on October 1, 2025.
AGL, CCRN and GOGL have been added to the Zacks Rank #5 (Strong Sell) List on August 20, 2025.
AGL Energy Limited (OTCPK:AGLNF) Q4 2025 Earnings Conference Call August 12, 2025 9:00 PM ET Company Participants Damien Nicks - MD, CEO & Director Gary Brown - Chief Financial Officer James Thompson - Head of Investor Relations Jo Egan - Chief Customer Officer Markus Brokhof - Chief Operating Officer Conference Call Participants Anthony Moulder - Jefferies LLC, Research Division Dale Johannes Koenders - Barrenjoey Markets Pty Limited, Research Division Gordon Alexander Ramsay - RBC Capital Markets, Research Division Henry Meyer - Goldman Sachs Group, Inc., Research Division Ian Myles - Macquarie Research Robert Koh - Morgan Stanley, Research Division Tom Allen - UBS Investment Bank, Research Division James Thompson Thank you for standing by, and welcome to the AGL Energy Full Year Results Briefing Conference Call. [Operator Instructions] I would now like to hand over the conference to Managing Director and Chief Executive Officer, Mr.
agilon health, inc. (NYSE:AGL ) Q2 2025 Earnings Conference Call August 5, 2025 5:30 PM ET Company Participants Evan Smith - Corporate Participant Jeffrey Alan Schwaneke - Executive VP & CFO Ronald Allan Williams - Chairman of the Board Conference Call Participants Andrew Mok - Barclays Bank PLC, Research Division Craig Jones - BofA Securities, Research Division Eduardo Enrique Ron - Truist Securities, Inc., Research Division Elizabeth Hammell Anderson - Evercore ISI Institutional Equities, Research Division George Robert Hill - Deutsche Bank AG, Research Division Jack Garner Slevin - Jefferies LLC, Research Division Jenny Shen - BTIG, LLC, Research Division Justin Lake - Wolfe Research, LLC Lance Arthur Wilkes - Sanford C.
The headline numbers for Agilon (AGL) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Agilon Health (AGL) came out with a quarterly loss of $0.25 per share versus the Zacks Consensus Estimate of a loss of $0.11. This compares to a loss of $0.07 per share a year ago.
AGL Energy said on Friday it had acquired South Australia's Virtual Power Plant (SAVPP) from Tesla , as the Australian power retailer looks to ramp up its battery storage capacity to drive green energy transition.
agilon health, inc. (NYSE:AGL ) Q1 2025 Results Conference Call May 6, 2025 4:30 PM ET Company Participants Evan Smith - Senior Vice President of Investor Relations Steve Sell - Chief Executive Officer Jeff Schwaneke - Chief Financial Officer Conference Call Participants Stephen Baxter - Wells Fargo Elizabeth Anderson - Evercore ISI Jailendra Singh - Truist Securities Justin Lake - Wolfe Research Amir Farahani - Bernstein Lisa Gill - JPMorgan Ryan Langston - TD Cowen Joanna Gajuk - Bank of America Ryan Daniels - William Blair Michael Ha - Baird Matthew Shea - Needham Daniel Grosslight - Citi Jenny Shen - BTIG George Hill - Deutsche Bank Whit Mayo - Leerink Partners Thomas Walsh - Barclays Operator Hello, everybody, and welcome to the agilon health First Quarter 2025 Earnings Conference Call.
Agilon Health (AGL) reported break-even quarterly earnings per share versus the Zacks Consensus Estimate of a loss of $0.01. This compares to earnings of $0.01 per share a year ago.